Renaissance Capital logo

RPID News

US IPO Weekly Recap: The summer IPO market heats up in a 13 IPO week

STVN

After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting initial filings.   Italian drug container supplier Stevanato Group (STVN)...read more

Microbial testing device provider Rapid Micro Biosystems prices upsized IPO at $20 high end

RPID

Rapid Micro Biosystems, which provides an automated microbial testing device and platform, raised $158 million by offering 7.9 million shares at $20, the high end of the range of $18 to $20. The company offered 1.3 million more shares than anticipated. Rapid Micro Biosystems' flagship product, the Growth Direct platform, automates the manual microbial quality control testing...read more

Microbial testing device provider Rapid Micro Biosystems sets terms for $125 million IPO

RPID

Rapid Micro Biosystems, which provides an automated microbial testing device and platform, announced terms for its IPO on Monday. The Lowell, MA-based company plans to raise $125 million by offering 6.6 million shares at a price range of $18 to $20. At the midpoint of the proposed range, Rapid Micro Biosystems would command a fully diluted market value of $828 million. ...read more

US IPO Week Ahead: Real estate, post-pandemic plays and more in a 15 IPO week

STVN

Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900 million at a $6.8 billion market cap. Controlled by its founding family, the profitable company supplies glass vials,...read more